Some 30 years after its discovery, phage display remains one of the most widely used methods of in vitro selection. Initially developed to revolutionize the generation of therapeutic antibodies, phage display is now the first choice for screening artificial binding proteins. Artificial binding proteins can be used as reagents to study protein-protein interactions, target posttranslational modifications, and distinguish between homologous proteins. They can also be used as research and affinity reagents, for diagnostic purposes, and as therapeutics. However, the ability to identify isoform-specific reagents remains highly challenging. We describe an adapted phage display protocol using an artificial binding protein (Affimer) for the selection of isoform-selective binding proteins.
INTRODUCTIONINTRODUCTION
There is a critical need for highly selective antibodies in biological research, diagnostics, and therapy. However, there is a widespread lack of reproducibility and selectivity of antibodies and a growing drive to use methods that directly yield recombinant binding reagents that can be sequenced and easily produced in a reproducible manner (1, 2) . These include artificial binding proteins such as DARPins (3), monobodies (4) , and Affimers [formerly referred to as Adhirons (5-7)], which offer the advantages of recombinant bacterial production as well as the ability to be expressed in mammalian cells to study protein function. The Adhiron scaffold, depicted in Fig. 1 , was derived from a consensus sequence of phytocystatins and was designed to constrain two separate variable peptide sequences for molecular recognition (5) . It is related in structure to a previously reported scaffold engineered from human Stefin A (8) . Nonantibody binding proteins derived from these two scaffolds are now referred to collectively as Affimers, and the utility of Affimer technology as affinity reagents has been demonstrated (7) .
Despite the growing number of methods for isolating protein-binding reagents, such as ribosomal display (9), cis display (10) , and mRNA display (11) , phage display remains the most widely used approach. Phage display was developed over 30 years ago (12) and has since been adapted for presenting large libraries of antibody fragments, peptides, and artificial binding proteins. Phage display is performed by mixing highly complex libraries of phage that display the binding moiety with purified target molecules normally presented as immobilized antigens on solid surfaces. This immobilization is commonly accomplished by direct adsorption to a solid surface or by chemical modification of the antigen using biotin linkers to immobilize them on streptavidin-coated surfaces. After three to five panning rounds, monoclonal phages displaying the selected binding reagents are tested to confirm their ability to bind to the target antigen. These clones are sequenced, and the coding regions are subcloned into expression vectors. This process typically takes 2 to 3 weeks and can yield reagents with binding affinities suitable for many applications.
Here, we describe a phage display strategy performed with an Affimer phage display library that uses relatively low amounts of target and nontarget homologous antigens, making it suitable for proteins that are expensive or difficult to express (5). This method (Fig. 2) allows selection of highly specific Affimer clones that are able to discriminate between protein isoforms with very similar three-dimensional structures. This method includes a process of negative selection wherein small amounts of the homologous proteins, for which you wish to deselect against, are premixed with the phage library from the second round of panning onward, both as immobilized proteins and as proteins in solution. In theory, this process allows capture or blocking of the cross-reactive Affimer-displaying phage, thereby allowing the highly selective Affimers to be enriched and isolated throughout the subsequent panning rounds. This protocol could potentially be used In each round of panning, the immobilized target (red dots) is incubated with a population of phage (green bars). After washing away any unbound phage, bound phage is eluted and propagated for subsequent rounds of selection. From pan 2 onward, the population of phage is first incubated with proteins homologous to the target protein to remove any phage that binds to these closely related homologs, before incubating with the intended target. ELISA, enzyme-linked immunosorbent assay. 
INSTRUCTIONS

Biotinylation of the Target Protein
The selection procedure is performed against a target protein that is biotinylated and captured on streptavidin-or NeutrAvidin-coated surfaces. Biotinylation reagents that use various conjugation chemistries are commercially available. We used the EZ-Link NHS-Biotin reagent, which reacts with primary amines such as the N termini of polypeptides or the side chain amine of lysine residues. 12-kDa protein (1 mg/ml) in a total volume of 100 l of PBS. 5. Incubate at room temperature for 30 min. 6. Desalt to remove any remaining biotin using Zeba Spin Desalting Columns (7000 MW cutoff) according to the manufacturer's instructions. 7. Mix with an equal volume of 80% glycerol and store at −20°C.
ELISA to Check Biotinylation
1. Aliquot 50 l per well of PBS to Nunc-Immuno MaxiSorp strips, and add 1 l of biotinylated protein to each well. Incubate overnight at 4°C. 2. Wash three times with 300 l of PBST per well with a microplate strip washer (for example, Tecan HydroFlex). 3. Add 200 l of 2× Blocking Buffer per well and incubate at 37°C for 2 to 3 hours. 4. Wash three times with 300 l of PBST per well on a microplate strip washer. 5. Dilute High Sensitivity Streptavidin-HRP (1:1000) in 2× Blocking Buffer and add 50 l per well. 6. Incubate for 1 hour at room temperature on a vibrating platform shaker, such as a Heidolph Vibramax 100 set to 300 rpm. 7. Wash six times with 300 l of PBST per well on a microplate strip washer. 8. Aliquot 50 l of TMB per well and allow to develop. Note the amount of time the plate is allowed to develop; usually, 2 to 3 min is sufficient. 9. Measure absorbance at 620 nm on a microplate reader.
Affimer Selection by Phage Display: First Panning Round
Day 1
1. Pick a colony of ER2738 E. coli cells into 5-ml 2TY medium plus tetracycline (12 g/ml) and incubate overnight in an orbital incubator at 37°C (230 rpm). 2. Aliquot 300 l of 2× Blocking Buffer per well into streptavidin-coated (HBC) eight-well strips and incubate overnight at 37°C. Set up four wells in total for each target (three wells for pre-panning the phage and one well for binding the target and panning with phage).
Day 2
3. Wash three times with 300 l of PBST per well on a microplate strip washer. 4. Aliquot 100 l of 2× Blocking Buffer per well into all wells. 5. Pre-pan the phage: To the first pre-pan well, add 5 l of phage library (about 10 12 colony forming units). Mix and incubate on a vibrating platform shaker for 40 min. Remove buffer from the second pre-pan well and transfer the buffer containing the phage from the first pre-pan well to the second pre-pan well. Incubate for 40 min, and then repeat for the third pre-pan well. 6. While pre-panning the phage: Add 20 l (up to 1 g) of the biotinylated target to the wells to be used for panning. Incubate for 1 to 2 hours at room temperature on the vibrating platform shaker. 7. Wash the wells containing the target three times with 300 l of PBST per well. 8. Transfer the phage from the pre-pan wells to the wells containing the target and incubate for 2 hours at room temperature on the vibrating platform shaker. 9. In the meantime, set up a fresh culture of ER2738 cells (8 ml per target) by diluting the overnight culture to an OD 600 (optical density at 600 nm) of ~0.2 and incubating for about 1 hour at 37°C at 230 rpm until OD 600 reaches ~0.6. 10. Wash the panning well 27 times in 300 l of PBST per well on the microplate strip washer. ). 20. Scrape the cells from the remaining plates. To do this, add 5 ml of 2TY carb [2TY medium containing carbenicillin (100 g/ml)] to the plate, scrape using a disposable plastic spreader, transfer to a 50-ml Falcon tube, and mix. Add an additional 2 ml of 2TY carb to scrape off any remaining cells. 21. Measure the absorbance at 600 nm of a 1:10 dilution to determine the dilution required for an 8-ml culture at an OD 600 of 0.2. 22. Dilute the cells in 2TY carb in 50-ml Falcon tubes to achieve an OD 600 of 0. 
4. Preblock plates for the KingFisher Flex magnetic particle processor for a minimum of 2 hours at 37°C: a. Preblock one well per target in a KingFisher Deepwell 96 Plate with 1 ml per well of 2× Blocking Buffer. These wells will be used for panning.
b. Preblock one well per target in a KingFisher 96 KF microplate (200 μl) with 300 l per well of 2× Blocking Buffer. These wells will be used to recover the streptavidin beads containing the bound target and selected phage. 5. Prepare one well per target in 4× KingFisher Deepwell 96 Plate with 950 l of 2× Blocking Buffer per well. These wells will be used for the wash steps in the KingFisher protocol (see Table 1 ). 6. Centrifuge the preblocked streptavidin beads at 800g for 1 min. Place the tube on the magnetic separation rack and discard the blocking buffer. 7. Replace with fresh 2× Blocking Buffer, resuspending in 100 l per 20 l of streptavidin beads. 8. Pre-pan the phage: Mix 125 l of phage-containing supernatant from the first panning round with 125 l of 2× Blocking Buffer and add 25 l of the preblocked streptavidin beads. For the negative selection, add the nonbiotinylated homologous protein at a concentration of 10 to 100 M. Incubate for 1 hour at room temperature on the rotator. 9. Centrifuge at 800g for 1 min and place the tube on the magnetic separation rack. Transfer the supernatant containing the phage to a fresh tube and add another 25 l of the preblocked streptavidin beads. Incubate for 1 hour at room temperature on the tube rotator. Centrifuge the tubes containing the biotinylated target at 800g for 1 min and place on the magnetic separation rack. 13. Wash the beads containing the biotinylated target three times in 500 l of 2× Blocking Buffer. 14. Centrifuge the tubes containing the pre-panned phage at 800g for 1 min and place on the magnetic separation rack for 1 min. 15. Transfer the supernatant containing the pre-panned phage to the beads containing the biotinylated target and resuspend. Transfer to the preblocked KingFisher Deepwell 96 Plate (step 4a). 16. Set up the KingFisher Flex to run the protocol "Phage_Display_Competition" (see Table 1 ). The total run time is 1 hour and 30 min. 17. The protocol will release the beads into 100 l of PBS. Transfer the beads to Eppendorf LoBind microcentrifuge tubes and add the following: 60 l of 10× Blocking Buffer 60 l of 80% glycerol 3 l of Halt Protease Inhibitor Cocktail (100×) 2.5 g of nonbiotinylated protein for deselection PBS to a total volume of 300 l 18. Incubate at room temperature on the tube rotator up to 24 hours. 19 . Pick a colony of ER2738 E. coli cells into 5 ml of 2TY medium with tetracycline (12 g/ml) and incubate overnight at 37°C (230 rpm).
Day 3
20. Preblock plates for the KingFisher Flex magnetic particle processor for a minimum of 2 hours at 37°C: a. Preblock one well per target in a KingFisher Deepwell 96 Plate with 1 ml per well of 2× Blocking Buffer. The competitively panned samples will be returned to this plate for washing and elution. b. Preblock one well per target two KingFisher 96 KF microplate (200 μl) with 300 l per well of 2× Blocking Buffer. One plate will be used for eluting with glycine, the other for eluting with triethylamine. 21. Prepare one well per target in a 4× KingFisher Deepwell 96 Plate with 950 l per well of 2× Blocking Buffer. This plate will be used for the wash steps in the KingFisher protocol (see Table 2 ). 22. Remove the buffer from the preblocked elution plates (step 20b). Aliquot 100 l per well of 0.2 M glycine (pH 2.2) into one plate.
Aliquot 100 l per well of triethylamine into the other plate. Remove the buffer from the preblocked KingFisher Deepwell 96 Plate (step 20a). 23. An hour before required, set up a fresh culture of ER2738 cells (8 ml per target) by diluting the overnight culture from step 19 to an OD 600 of ~0.2 and incubating for about 1 hour at 37°C (230 rpm) until OD 600 reaches ~0.6. 24. After 24 hours of competitive binding, centrifuge the samples at 800g for 30 s, resuspend, and transfer to the preblocked KingFisher Deepwell 96 Plate. 25. Set up the KingFisher Flex to run the protocol "Phage_Display_Wash_Elute" (see Table 2 ). 26. The protocol is set up to incubate the beads in glycine for 10 min and to elute the phage. As soon as this is finished, neutralize by adding 15 l of 1 M tris-HCl (pH 9.1). Mix and add to the 8-ml aliquots of ER2738 cells. 27. The beads are transferred into triethylamine for 6 min to elute any remaining phage. As soon as this is finished, neutralize by adding 50 l of 1 M tris-HCl (pH 7.0). Mix and add to the ER2738 cells. 28. Incubate the cells for 1 hour at 37°C (no shaking or shake at low speed, 90 rpm at maximum). Mix at least once during the incubation period. 29. Centrifuge the cells at 3000g for 5 min to resuspend in a smaller volume and plate onto LB carb plates. Incubate overnight at 37°C. 1. Aliquot 300 l per well of 2× Blocking Buffer into NeutrAvidin-coated (HBC) eight-well strips and incubate overnight at 37°C. Set up six wells in total for each target (four wells for pre-panning the phage, one for panning against the target, and a negative control for panning against the deselected protein).
Day 2
2. Wash three times with 300 l of PBST per well on a microplate strip washer. 
TROUBLESHOOTING Biotinylation Blocks the Active Site of the Target Protein
The biotinylation reagent (EZ-Link NHS-Biotin) reacts with primary amines such as the N termini of polypeptides or the amine of the side chain of lysine residues. Therefore, if there are lysine residues present in a functional region of a target protein, biotinylation of these residues could block access for binding in the selection process. Other biotinylation reagents that target different functional groups or residues are available. For example, the EZ-Link HPDP-Biotin reagent (Thermo Fisher Scientific, catalog no. 21341) reacts with sulfhydryls, such as the side chain of cysteine residues. An alternative to chemical conjugation methods of biotinylation is enzymatic biotinylation. This is most often achieved by fusing the protein of interest with a biotin acceptor peptide. The 15-amino acid peptide tag (GLNDIFEAQKIEWHE) serves as a highly specific recognition site for E. coli biotin ligase, which covalently attaches a single biotin molecule. Enzymatic biotinylation can be carried out in vitro but can also be achieved in vivo in the appropriate expression strains of E. coli.
The Selection Procedure Is Too Stringent
Occasionally, our negative selection method has failed to select binders. This may happen when sequence homology between the two isoforms is especially high. This can result in the selection of weaker binders, which may be lost during the stringent deselection process. To decrease stringency, the 24-hour incubation step during the second and third panning rounds can be removed, and the phage can be eluted immediately after washing.
NOTES AND REMARKS
A Nature Protocols paper described an in-depth protocol for a related technique, the selection of human antibody fragments by phage display (13) . This method could of course be adapted for other phage display libraries, including the Affimer library; however, this method does not describe a strategy to deselect against homologous proteins. Furthermore, our protocol uses lower amounts of target in each round of selection, which is advantageous for expensive or poorly expressed targets.
Our method was originally developed to select isoform-specific inhibitors of SUMO-dependent protein-protein interactions (14) . Gilbreth et al. (15) described an alternative method, also using phage display for selection, and were successful in isolating isoform-specific monobody inhibitors of yeast SUMO (ySUMO) and the human SUMO-1 isoform (hSUMO-1). The authors expressed the targets (ySUMO, hSUMO-1, and hSUMO-2) as C-terminal fusions to a glutathione S-transferase (GST) variant engineered to be devoid of cysteine residues except for a single cysteine for the purpose of biotinylation using the EZ-Link HPDP-Biotin reagent. Monobody-displaying phage particles were preincubated with nonbiotinylated GST from round 2 of selection to remove binders to GST. They did not use this method of deselection to remove binders against the different isoforms of SUMO. They first identified monobody binders to ySUMO, then, using crystal structure analysis of the binding mechanism, designed a SUMO-targeted monobody library that was independently screened against the different isoforms. Although this method isolated specific binders to hSUMO-1, it failed to isolate hSUMO-2-specific binders.
Our method has been successful in generating specific binders to numerous proteins and protein domains. The advantages of using the deselection method described here are that it requires only small amounts of target proteins, the process is relatively quick, and selection can be done from a large naïve randomized library. The stringency can also be adjusted by altering incubation times and wash steps.
